Solutions
AI Solutions for Optimized Clinical Trial Design
NetraMark offers AI Solutions to Trial Sponsors, CROs, and biotechnology companies across the globe.
Our AI Solutions are structured to uncover Actionable insights from your trial data that better define your target study population and ensure greater success for your next trial. Including:
Hidden subpopulations characterized by treatment response type
Hand-crafted Personas detailing preferred patient traits that, if recruited, would improve the success of your trial
Causal variables explaining the reasons for treatment response, placebo response, and SAEs
Access to NetraMark’s actionable insights enables you to:
Enrich your Protocol with trial-specific eligibility criteria to find the people who are more likely to benefit from your treatment
Better understand the heterogeneous disease you are developing treatments for and the human traits that influence your treatment’s effectiveness
Drive higher success rates in your pivotal trial and be better equipped with explainable data for regulatory approval application submissions
When NetraMark fits into the Sponsor Journey
After Phase 1, 2 or 3 trial data readouts, sponsors are in a position to learn from their data in order to make key changes to their trial design before beginning recruitment for subsequent trials.
NetraMark empowers you to adjust your trial design to attract patients more likely to benefit from your drug. Our AI guides sponsors in the right direction, delivering insights that have the power to improve success, execute trials more efficiently, save on costs, realign asset strategies, support regulatory submissions, and safely bring life-saving treatments to market.
What Does NetraMark Do With Your Trial Data?
- We secure and prepare your trial readout data for our AI to review, uncontaminated by other data.
- Through a combination of human and AI interpretation, we deliver science-based insights hypothesized to improve the success of your trial.
- We provide you with next-step strategies you could take to implement our findings and improve your study design.
Our AI Solutions for Clinical Trials
Identify & Characterize Your Target Population
*After Phase 1, 2, or 3 data readouts
NetraAI Personas
Identify what traits determine favorable and unfavorable participants in your trial.
Deliverable: Insights report with personas and clinical interpretation.
Value: Enrich eligibility criteria in next phase protocol.
Optimize Participant Recruitment
*During active trial recruitment
Ceres Participant Scoring
Learn which trajectory each participant in your trial is most likely to follow.
Deliverable: Participant-to-Persona matching performance scores.
Value: Recruit the right participants for your trial.
Ensure Site
Integrity
*During active trial recruitment
Ceres Site Vigilance
Reveal which of your trial sites should be investigated for anomalous behavior.
Deliverable: Insights report with explanations for flagged sites.
Value: Identify anomalous behavior at sites.
*Request a meeting to determine pricing based on needs, size of project, population variables, study arms, number of drugs, dosage amounts, etc.